Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
FEBS Letters|May 4, 1992
Design, synthesis and solution structure of a renin inhibitor. Structural constraints from NOE, and homonuclear and heteronuclear coupling constants combined with distance geometry calculationsM D Reily, V Thanabal, E A Lunney, et al.Peptide Research|September 1, 1989
Psi [CH2NH] backbone-modified peptides: first unequivocal observation of a C7 structure in a linear peptideC Toniolo, G Valle, M Crisma, et al.Journal of Medicinal Chemistry|November 26, 1993
Analyses of ligand binding in five endothiapepsin crystal complexes and their use in the design and evaluation of novel renin inhibitorsE A Lunney, H W Hamilton, J C Hodges, et al.Journal of Medicinal Chemistry|March 20, 1992
Renin inhibitors containing alpha-heteroatom amino acids as P2 residuesJ T Repine, J S Kaltenbronn, A M Doherty, et al.Journal of Medicinal Chemistry|July 1, 1991
Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonateJ T Repine, R J Himmelsbach, J C Hodges, et al.Journal of Medicinal Chemistry|February 1, 1990
Renin inhibitors containing isosteric replacements of the amide bond connecting the P3 and P2 sitesJ S Kaltenbronn, J P Hudspeth, E A Lunney, et al.Journal of Medicinal Chemistry|April 1, 1991
New inhibitors of human renin that contain novel replacements at the P2 siteA M Doherty, J S Kaltenbronn, J P Hudspeth, et al.Journal of Medicinal Chemistry|June 1, 1986
Modified di- and tripeptides of the C-terminal portion of oxytocin and vasopressin as possible cognition activation agentsE D Nicolaides, F J Tinney, J S Kaltenbronn, et al.Journal of Medicinal Chemistry|June 23, 1999
Butenolide endothelin antagonists with improved aqueous solubilityW C Patt, X M Cheng, J T Repine, et al.Journal of Medicinal Chemistry|March 28, 1997
Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonistsW C Patt, J J Edmunds, J T Repine, et al.Pageof 1